BioCryst announces approval of Orladeyo (berotralstat) by Swissmedic

7 June 2022 -  -- BioCryst Pharmaceuticals today announced that Swissmedic has granted marketing authorisation for oral, once-daily Orladeyo (berotralstat) ...

Read more →

Swiss drug prices still soar above European levels

31 May 2022 - Compared with nine other European countries, Switzerland remains a high-price island for medicines, according to an annual ...

Read more →

Hansa Biopharma announces temporary marketing authorisation in Switzerland for Idefirix (imlifidase) in kidney transplantation

13 May 2022 - Idefirix is now granted marketing authorisation within the EU, the U.K., Israel and Switzerland. ...

Read more →

Swissmedic has accepted the new oral edarvarone formulation for the treatment of ALS

25 April 2022 - Mitsubishi Tanabe Pharma announced that Swissmedic has accepted the filing for an investigational oral suspension formalation ...

Read more →

Swissmedic grants conditional marketing authorisation for Novavax COVID-19 vaccine

13 April 2022 - Nuvaxovid is the first protein-based COVID-19 vaccine authorised for use in Switzerland. ...

Read more →

Switzerland approves its first protein-based Covid vaccine

15 April 2022 - Swissmedic announced its approval on Wednesday making Nuvaxovid the first protein-based vaccine to be licensed in Switzerland.  ...

Read more →

MorphoSys and Incyte announce Swissmedic temporary approval of Minjuvi (tafasitamab) in combination with lenalidomide for the treatment of adults with r/r DLBCL

22 March 2022 - Minjuvi is a new therapeutic option for eligible DLBCL patients in Switzerland addressing an urgent unmet medical ...

Read more →

BeiGene announces approval for Brukinsa (zanubrutinib) by Swissmedic for treatment of adult patients with Waldenström’s macroglobulinaemia

17 February 2022 - With this approval, Brukinsa is now approved in 44 markets as BeiGene continues to advance its global ...

Read more →

Novavax files for conditional marketing authorisation of COVID-19 Vaccine in Switzerland

14 February 2022 - Novavax today announced its submission to Swissmedic, the Swiss Agency for Therapeutic Products, for conditional marketing authorisation ...

Read more →

Swissmedic grants temporary authorisation to Xevudy for COVID-19 patients

14 January 2022 - Corona medication Xevudy from GSK (sotrovimab) granted temporary authorisation in Switzerland ...

Read more →

Celltrion wins conditional nod for Regkirona in Switzerland

14 January 2022 - Celltrion said that Swiss Medic, Switzerland’s drug administration, has temporary authorisation for Regkirona (regdanvimab). ...

Read more →

Swiss regulator approves Roche-Regeneron COVID-19 drug

27 December 2021 - The Swiss medicines agency, Swissmedic, has given the green light to the monoclonal antibody cocktail Ronapreve developed ...

Read more →

Janssen COVID-19 booster shot approved in Switzerland

28 December 2021 - Medicines regulator Swissmedic has approved the booster of the single-dose vaccine from Johnson & Johnson. ...

Read more →

Pfizer/BioNTech vaccine approved for children by Swiss regulator

10 December 2021 - The Swiss medical regulator has approved the use of Pfizer/BioNTech’s Covid-19 vaccine for children aged five to ...

Read more →

Swiss regulator approves Pfizer/BioNTech booster for 16 and up

23 November 2021 - Swissmedic has approved the extension of COVID-19 boosters for the Pfizer/BioNTech vaccine to all people aged 16 ...

Read more →